Please provide your email address to receive an email when new articles are posted on . Breye Therapeutics has begun dosing in its phase 1b/2a trial of oral danegaptide for treatment of diabetic ...

CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics, Inc., a biopharmaceutical company focused on advancing first-in-class treatments for the eye, today announced promising results in diabetic ...

SAN FRANCISCO, Aug. 3, 2023 /PRNewswire/ -- Perfuse Therapeutics, a biopharmaceutical company pioneering transformational therapies to treat ischemia-induced ocular diseases is pleased to announce the ...

Diabetic retinopathy is a complication of diabetes that affects the back of the eye and can cause vision loss, blurry vision ...

Non-proliferative diabetic retinopathy is the earliest stage of this diabetes complication. You may not have symptoms, and medical treatments may not be needed aside from diabetes management. As ...